[ad_1]
WEDNESDAY, May 20, 2020 (HealthDay News) — Lawsuits claiming that talc-based Johnson’s Baby Powder has caused cancer have led to a plunge in sales in the United States and Canada, so Johnson & Johnson said Tuesday it is ending sales of the product in those two countries.
The company said the talc-based powder is safe and will still be sold in other countries, the Associated Press reported.
About 19,400 lawsuits alleging that J&J’s talcum powder caused ovarian cancer or mesothelioma, a cancer that affects the lungs and other organs, have been launched against the company.
To date, J&J has won 12 cases, lost 15, and there have been seven mistrials. All of the lost cases have either been overturned on appeal or are still being appealed, the AP reported.
Copyright © 2019 HealthDay. All rights reserved.
SLIDESHOW
Childhood Diseases: Measles, Mumps, & More
See Slideshow
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
